Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Precancerous Conditions 1Keratosis, Actinic 1Carcinoma, Squamous Cell 1

Interventions

3-ingenyl angelate 39Imiquimod 22Aminolevulinic Acid 22Photochemotherapy 16methyl 5-aminolevulinate 12Fluorouracil 11Diclofenac 11Gels 10Cryotherapy 6Solutions 5BF-200 ALA 5tirbanibulin 4Radiotherapy 4Prilocaine 4Lidocaine 4LEO 43204 4Petrolatum 3Ointments 3Cryosurgery 3calcipotriene 2SR-T100 2Niacinamide 2Blue Light 21-phenyl-3,3-dimethyltriazene 2tazarotene 1potassium dobesilate 1perillyl alcohol 1endonuclease V, phage T4 1dexpanthenol 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Keratosis, Actinic × Excipients × Clear all
NCT02844777 2023-01-12

Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis

Vidac Pharma

Phase 2 Completed
93 enrolled 13 charts
DermatologicOther neoplasm

Carcinoma, Squamous Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡